337 related articles for article (PubMed ID: 10858615)
1. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
[TBL] [Abstract][Full Text] [Related]
3. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
5. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
6. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.
Pérez-Navarro E; Arenas E; Reiriz J; Calvo N; Alberch J
Neuroscience; 1996 Nov; 75(2):345-52. PubMed ID: 8931001
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
[TBL] [Abstract][Full Text] [Related]
8. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.
Pérez-Navarro E; Arenas E; Marco S; Alberch J
Eur J Neurosci; 1999 Jan; 11(1):241-9. PubMed ID: 9987028
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
[TBL] [Abstract][Full Text] [Related]
12. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.
Marco S; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurobiol; 2002 Mar; 50(4):323-32. PubMed ID: 11891666
[TBL] [Abstract][Full Text] [Related]
13. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo.
Pérez-Navarro E; Alberch J; Neveu I; Arenas E
Neuroscience; 1999; 91(4):1257-64. PubMed ID: 10391433
[TBL] [Abstract][Full Text] [Related]
15. Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum.
Marco S; Canudas AM; Canals JM; Gavaldà N; Pérez-Navarro E; Alberch J
Exp Neurol; 2002 Apr; 174(2):243-52. PubMed ID: 11922665
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.
Alexi T; Venero JL; Hefti F
Neuroscience; 1997 May; 78(1):73-86. PubMed ID: 9135090
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA.
Venero JL; Beck KD; Hefti F
Neuroscience; 1994 Jul; 61(2):257-68. PubMed ID: 7969907
[TBL] [Abstract][Full Text] [Related]
18. NGF but not GDNF or neurturin enhance acetylcholine tissue levels in striatal organotypic brain slices.
Fischer HP; Marksteiner J; Ransmayr G; Saria A; Humpel C
Int J Dev Neurosci; 1998 Aug; 16(5):391-401. PubMed ID: 9829175
[TBL] [Abstract][Full Text] [Related]
19. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
